Osteonecrosis of the Jaw in a Breast Cancer Patient Treated with Everolimus and a Single Dose of Zoledronic Acid.
Department of Medical Oncology, University Hospital of ModenaVia del Pozzo, Modena, Italy.
Claudia
C
Omarini
Department of Medical Oncology, University Hospital of ModenaVia del Pozzo, Modena, Italy.
Maria E
ME
Filieri
Department of Medical Oncology, University Hospital of ModenaVia del Pozzo, Modena, Italy.
Roberta
R
Depenni
Department of Medical Oncology, University Hospital of ModenaVia del Pozzo, Modena, Italy.
Giulia
G
Grizzi
Department of Medical Oncology, University Hospital of ModenaVia del Pozzo, Modena, Italy.
Stefano
S
Cascinu
Department of Medical Oncology, University Hospital of ModenaVia del Pozzo, Modena, Italy.
Federico
F
Piacentini
D000730:Androstadienes / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D054893:Cone-Beam Computed Tomography; D003937:Diagnosis, Differential; D000068338:Everolimus / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced / Q000175:diagnosis* / Q000000981:diagnostic imaging; D008408:Mastectomy; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced / Q000175:diagnosis* / Q000000981:diagnostic imaging
D000730:Androstadienes; D050071:Bone Density Conservation Agents; D000068338:Everolimus; C056516:exemestane